Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?
Arnould L; Gelly M; Penault-Llorca F; Benoit L; Bonnetain F; Migeon C; Cabaret V; Fermeaux V; Bertheau P; Garnier J; Jeannin JF; Coudert B; British Journal Of Cancer, 2006, vol. 94, issue 2, p 259, ISSN 00070920. ISBN 00070920.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef